| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Nemerson Y | |
| Rauch U | |||
| P433 | issue | 4 | |
| P304 | page(s) | 139-143 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Trends in Cardiovascular Medicine | Q1850265 |
| P1476 | title | Tissue factor, the blood, and the arterial wall | |
| P478 | volume | 10 |
| Q26786677 | "Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation |
| Q37715189 | Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis. |
| Q52927674 | Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. |
| Q36044569 | Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases |
| Q28166830 | Catheter based intracoronary brachytherapy leads to increased platelet activation |
| Q33878775 | Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease |
| Q28219643 | Clopidogrel-mediated reduction of circulating tissue factor in patients with stable coronary artery disease |
| Q42506566 | Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein |
| Q37817007 | Ectosomes as immunomodulators |
| Q42185904 | Effect of circulating tissue factor on hypercoagulability in type 2 diabetes mellitus studied by rheometry and dielectric blood coagulometry |
| Q50965594 | Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats. |
| Q36839933 | Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation |
| Q52921832 | Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells. |
| Q54601092 | Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. |
| Q36973405 | Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor |
| Q35088528 | New understanding, diagnosis, and prognosis of atherothrombosis and the role of imaging |
| Q63367680 | Pathogenesis and pathophysiology of pneumococcal meningitis |
| Q46909421 | Peanuts improve blood glutathione, HDL-cholesterol level and change tissue factor activity in rats fed a high-cholesterol diet |
| Q34777701 | Plasminogen activators in inflammation and sepsis |
| Q34263823 | Platelets in Inflammation and Thrombosis |
| Q28246124 | Thrombin and vascular inflammation |
| Q37349105 | Thromboembolic disease in vasculitis |
| Q48124567 | Tissue factor activities of streptozotocin induced diabetic rat tissues and the effect of peanut consumption |
| Q53619159 | Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus. |
| Q30399242 | Tissue factor levels in type 2 diabetes mellitus. |
| Q35684155 | Tissue factor: a key molecule in hemostatic and nonhemostatic systems |
| Q28188180 | Tissue factor: in at the start...and the finish? |
| Q35976478 | Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia |
Search more.